We’ve streamlined our proven operating model to the distinct needs of generics sponsors. From bioequivalence studies to more complex therapeutic equivalence trials, we can give you what you’ve been looking for: a dedicated partner to fully manage study design and delivery at competitive pricing. You’ll still be able to harness our industry-leading global site network, deep therapeutic expertise and proprietary technology to more rapidly and predictably execute your generic clinical endpoint studies.